TAK-079A Study to Evaluate the Safety of TAK-079 PAISLEY-SLEA Phase II study to evaluate a novel, oral therapy in SLE ORKIDSA study to evaluate the effects of krill oil in SLE LOTUSA Phase III study to evaluate Stelara® in SLE DIVINEA study to evaluate a novel imaging procedure to access Lupus Nephritis (LN) RIFLEA study … 10 Lupus Therapeutics Studies Currently Underway
Caroline Donovan, Manager of Patient Engagement at Lupus Research Alliance (LRA) affiliate Lupus Therapeutics (LT) took part in a panel discussion at the DIA 2019 (Drug Information Association) annual meeting, aimed at finding ways to make sure that diverse groups of patients can make informed choices about joining a clinical trial. Ms. Donovan explained that … Lupus Research Alliance and Lupus Therapeutics – Leading Voices in Trial Diversity
Making new and efficacious lupus therapies available to patients has long been a major focus of the Lupus Research Alliance, and today we’ve taken an important step toward that aim. Based on a breakthrough discovery made by Betty Diamond, MD of Feinstein Institutes for Medical Research, Meggan Mackay, MD, MS, also at Feinstein, will conduct a … Taking Scientific Discovery: From Lab Bench to You